BioMarin Pharmaceutical Acquires Zystor Therapeutics for $115,000,000
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=55f39173-fd7d-4d4e-bb40-e1f8f7dc457b&Preview=1
Date 8/17/2010
Company Name Zystor Therapeutics
Mailing Address 10437 Innovation Drive Milwaukee, WI 53226-4838
Company Description ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs.
M&A Terms Under the terms of the agreement, BioMarin acquired ZyStor for $22 million upfront and up to an additional $93 million if certain development, regulatory and commercial milestones are achieved.